Full Year 2026 ALS Ltd Earnings Call Transcript
Key Points
- ALS Ltd (CPBLF) achieved its fiscal year '27 targets a year early, driven by strong organic growth.
- Revenue for fiscal year '26 was $3.32 billion, up 10.7%, with organic growth of 8.4%.
- Underlying EBIT increased by 19.3% to $599 million, with an EBIT margin improvement of 129 basis points to 18%.
- The company declared a dividend increase of 10.1%, equating to a 57% payout ratio of underlying net profit after taxes.
- ALS Ltd (CPBLF) maintained a strong balance sheet with leverage at 1.5 times, providing flexibility for future growth investments.
- The environmental division in the Americas underperformed due to integration challenges and market-specific issues.
- The company faced supply chain disruptions from the Middle East conflict, with an estimated financial impact of $5 to $10 million.
- There was a slight organic revenue decline of 1.6% in the pharma division.
- ALS Ltd (CPBLF) experienced a cybersecurity event, though it was contained with no material financial impact anticipated.
- The integration of recent acquisitions, particularly in Europe, faced challenges, affecting performance.
Good day, and thank you for standing by. Welcome to ALS Limited FY26 results briefing. (Operator Instructions) Please be advised that today's conference is being recorded.
I'd now like to turn the call over to your first speaker today. It's Malcom Deane, CEO and Managing Director. Thank you. Please go ahead.
Thanks, Desmond, and good morning and thank you everyone for joining us today. It's been a very strong year for Ires, and we've delivered record results reflecting our ability to achieve strong growth while staying disciplined on margin performance, cash generation, and capital allocation. As always, I'm joined by Stuart Hutton, our Chief Financial Officer. We speak for around 30 minutes and then we will open for questions.
Three years ago, we set ourselves ambitious fiscal year '27 targets. I'm pleased to report that we have achieved these targets 12 months early, while refining our strategy and focus for the future. What's most pleasing is that we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
